nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—RAF1—brainstem—Behcet's disease	0.0348	0.072	CbGeAlD
Vemurafenib—RAF1—eye—Behcet's disease	0.0339	0.0701	CbGeAlD
Vemurafenib—BRAF—midbrain—Behcet's disease	0.0333	0.0689	CbGeAlD
Vemurafenib—RAF1—skin of body—Behcet's disease	0.0295	0.061	CbGeAlD
Vemurafenib—RAF1—mammalian vulva—Behcet's disease	0.0269	0.0556	CbGeAlD
Vemurafenib—RAF1—cardiac atrium—Behcet's disease	0.0257	0.0532	CbGeAlD
Vemurafenib—RAF1—medulla oblongata—Behcet's disease	0.0242	0.0502	CbGeAlD
Vemurafenib—RAF1—midbrain—Behcet's disease	0.0222	0.0459	CbGeAlD
Vemurafenib—RAF1—spinal cord—Behcet's disease	0.0216	0.0448	CbGeAlD
Vemurafenib—BRAF—brain—Behcet's disease	0.0209	0.0433	CbGeAlD
Vemurafenib—RAF1—nervous system—Behcet's disease	0.0182	0.0377	CbGeAlD
Vemurafenib—RAF1—central nervous system—Behcet's disease	0.0175	0.0363	CbGeAlD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.0163	0.0316	CbGpPWpGaD
Vemurafenib—BRAF—Integrin-mediated Cell Adhesion—ITGB2—Behcet's disease	0.0163	0.0315	CbGpPWpGaD
Vemurafenib—ORM1—spinal cord—Behcet's disease	0.0149	0.0309	CbGeAlD
Vemurafenib—BRAF—Integrin-mediated Cell Adhesion—ITGAL—Behcet's disease	0.0147	0.0284	CbGpPWpGaD
Vemurafenib—RAF1—brain—Behcet's disease	0.0139	0.0288	CbGeAlD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.0137	0.0265	CbGpPWpGaD
Vemurafenib—ABCC1—mammalian vulva—Behcet's disease	0.0134	0.0278	CbGeAlD
Vemurafenib—ABCC1—cardiac atrium—Behcet's disease	0.0129	0.0266	CbGeAlD
Vemurafenib—ORM1—nervous system—Behcet's disease	0.0126	0.026	CbGeAlD
Vemurafenib—ALB—Scavenging of heme from plasma—APOA1—Behcet's disease	0.0122	0.0235	CbGpPWpGaD
Vemurafenib—ORM1—central nervous system—Behcet's disease	0.0121	0.0251	CbGeAlD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.0113	0.0219	CbGpPWpGaD
Vemurafenib—RAF1—Integrin-mediated Cell Adhesion—ITGB2—Behcet's disease	0.0112	0.0218	CbGpPWpGaD
Vemurafenib—ABCG2—mammalian vulva—Behcet's disease	0.0111	0.023	CbGeAlD
Vemurafenib—BRAF—Bladder Cancer—CXCL8—Behcet's disease	0.011	0.0212	CbGpPWpGaD
Vemurafenib—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.0108	0.021	CbGpPWpGaD
Vemurafenib—RAF1—Integrin-mediated Cell Adhesion—ITGAL—Behcet's disease	0.0101	0.0196	CbGpPWpGaD
Vemurafenib—ABCG2—medulla oblongata—Behcet's disease	0.01	0.0208	CbGeAlD
Vemurafenib—ABCC1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00991	0.0192	CbGpPWpGaD
Vemurafenib—CYP2D6—brainstem—Behcet's disease	0.00986	0.0204	CbGeAlD
Vemurafenib—BRAF—Focal Adhesion—ITGB2—Behcet's disease	0.00973	0.0188	CbGpPWpGaD
Vemurafenib—ABCG2—midbrain—Behcet's disease	0.00917	0.019	CbGeAlD
Vemurafenib—ABCG2—spinal cord—Behcet's disease	0.00894	0.0185	CbGeAlD
Vemurafenib—BRAF—Focal Adhesion—ITGAL—Behcet's disease	0.00877	0.017	CbGpPWpGaD
Vemurafenib—ALB—brain—Behcet's disease	0.00843	0.0174	CbGeAlD
Vemurafenib—RAF1—Endothelin Pathways—NOS3—Behcet's disease	0.00812	0.0157	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-11 Signaling Pathway—ICAM1—Behcet's disease	0.00809	0.0157	CbGpPWpGaD
Vemurafenib—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.00787	0.0152	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—Behcet's disease	0.00725	0.014	CbGpPWpGaD
Vemurafenib—ABCC1—brain—Behcet's disease	0.00696	0.0144	CbGeAlD
Vemurafenib—RAF1—Focal Adhesion—ITGB2—Behcet's disease	0.00673	0.013	CbGpPWpGaD
Vemurafenib—BRAF—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—Behcet's disease	0.00659	0.0127	CbGpPWpGaD
Vemurafenib—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.00623	0.012	CbGpPWpGaD
Vemurafenib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.00613	0.0119	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—ITGAL—Behcet's disease	0.00607	0.0117	CbGpPWpGaD
Vemurafenib—ABCG2—brain—Behcet's disease	0.00576	0.0119	CbGeAlD
Vemurafenib—RAF1—IL-3 Signaling Pathway—CXCL8—Behcet's disease	0.00525	0.0102	CbGpPWpGaD
Vemurafenib—CYP3A4—nervous system—Behcet's disease	0.00525	0.0109	CbGeAlD
Vemurafenib—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.00523	0.0101	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—NOS3—Behcet's disease	0.00517	0.01	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—NOS3—Behcet's disease	0.00517	0.01	CbGpPWpGaD
Vemurafenib—CYP2D6—nervous system—Behcet's disease	0.00517	0.0107	CbGeAlD
Vemurafenib—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.00515	0.00996	CbGpPWpGaD
Vemurafenib—CYP3A4—central nervous system—Behcet's disease	0.00505	0.0105	CbGeAlD
Vemurafenib—CYP2D6—central nervous system—Behcet's disease	0.00497	0.0103	CbGeAlD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—SERPINE1—Behcet's disease	0.00495	0.00957	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—SERPINE1—Behcet's disease	0.00487	0.00943	CbGpPWpGaD
Vemurafenib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.00485	0.00938	CbGpPWpGaD
Vemurafenib—RAF1—AGE/RAGE pathway—NOS3—Behcet's disease	0.00467	0.00903	CbGpPWpGaD
Vemurafenib—BRAF—Corticotropin-releasing hormone—CXCL8—Behcet's disease	0.00459	0.00887	CbGpPWpGaD
Vemurafenib—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.00458	0.00887	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—Behcet's disease	0.00456	0.00881	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—CAT—Behcet's disease	0.00431	0.00835	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00426	0.00825	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—NOS3—Behcet's disease	0.00421	0.00815	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MEFV—Behcet's disease	0.0042	0.00812	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—APOB—Behcet's disease	0.00419	0.0081	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.00416	0.00806	CbGpPWpGaD
Vemurafenib—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	0.00414	0.00801	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—TNF—Behcet's disease	0.00414	0.008	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—CXCL8—Behcet's disease	0.00413	0.00798	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.00407	0.00788	CbGpPWpGaD
Vemurafenib—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.00403	0.00779	CbGpPWpGaD
Vemurafenib—CYP2D6—brain—Behcet's disease	0.00395	0.00817	CbGeAlD
Vemurafenib—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.00387	0.00749	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00385	0.00744	CbGpPWpGaD
Vemurafenib—RAF1—Ceramide signaling pathway—TNF—Behcet's disease	0.00372	0.00719	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ERAP1—Behcet's disease	0.00359	0.00695	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—NOS3—Behcet's disease	0.00358	0.00692	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	0.00343	0.00663	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—SERPINE1—Behcet's disease	0.00337	0.00652	CbGpPWpGaD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.00333	0.00645	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	0.00333	0.00644	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—APOA1—Behcet's disease	0.00331	0.00641	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00329	0.00636	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—HLA-B—Behcet's disease	0.00327	0.00633	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.00323	0.00625	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—CXCL8—Behcet's disease	0.00317	0.00614	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.00317	0.00613	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—ICAM1—Behcet's disease	0.00315	0.00609	CbGpPWpGaD
Vemurafenib—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.00311	0.00601	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ITGB2—Behcet's disease	0.00307	0.00595	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—NOS3—Behcet's disease	0.00299	0.00579	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.00288	0.00557	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CXCL8—Behcet's disease	0.00285	0.00552	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—APOA1—Behcet's disease	0.00284	0.0055	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ITGAL—Behcet's disease	0.00277	0.00536	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—ITGB2—Behcet's disease	0.00277	0.00535	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00271	0.00524	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ITGB2—Behcet's disease	0.00266	0.00514	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	0.00263	0.00509	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—SERPINE1—Behcet's disease	0.00263	0.00509	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.0025	0.00484	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MEFV—Behcet's disease	0.00244	0.00473	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ITGAL—Behcet's disease	0.0024	0.00464	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.00238	0.0046	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00234	0.00453	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00227	0.0044	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.00227	0.00438	CbGpPWpGaD
Vemurafenib—ALB—Platelet degranulation—SERPINE1—Behcet's disease	0.00226	0.00436	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—TNF—Behcet's disease	0.00221	0.00427	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ERAP1—Behcet's disease	0.00218	0.00422	CbGpPWpGaD
Vemurafenib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00215	0.00416	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00209	0.00404	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TNF—Behcet's disease	0.00197	0.00382	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	0.00191	0.00369	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00186	0.0036	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR1—Behcet's disease	0.00185	0.00359	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.00184	0.00356	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—ITGB2—Behcet's disease	0.00165	0.0032	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CTLA4—Behcet's disease	0.00165	0.00319	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ITGB2—Behcet's disease	0.00161	0.00312	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR1—Behcet's disease	0.00158	0.00306	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—Behcet's disease	0.00155	0.003	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—APOB—Behcet's disease	0.00153	0.00295	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—ITGAL—Behcet's disease	0.00149	0.00289	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ITGAL—Behcet's disease	0.00145	0.00281	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.00145	0.0028	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00145	0.0028	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00138	0.00266	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—Behcet's disease	0.00136	0.00264	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00132	0.00255	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00131	0.00253	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HLA-B—Behcet's disease	0.00127	0.00246	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00126	0.00244	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.00123	0.00238	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00123	0.00238	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-B—Behcet's disease	0.00122	0.00236	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—APOA1—Behcet's disease	0.00121	0.00234	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00115	0.00223	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR1—Behcet's disease	0.0011	0.00212	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00109	0.00211	CbGpPWpGaD
Vemurafenib—BRAF—Disease—APOB—Behcet's disease	0.00107	0.00207	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00104	0.00202	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00104	0.002	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTLA4—Behcet's disease	0.001	0.00194	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.001	0.00194	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ICAM1—Behcet's disease	0.000991	0.00192	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—SERPINE1—Behcet's disease	0.000958	0.00185	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS3—Behcet's disease	0.000915	0.00177	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000911	0.00176	CbGpPWpGaD
Vemurafenib—BRAF—Disease—APOA1—Behcet's disease	0.000845	0.00163	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—APOB—Behcet's disease	0.000821	0.00159	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—APOB—Behcet's disease	0.000747	0.00145	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000747	0.00145	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-B—Behcet's disease	0.00074	0.00143	CbGpPWpGaD
Vemurafenib—RAF1—Disease—APOB—Behcet's disease	0.000738	0.00143	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—APOB—Behcet's disease	0.000732	0.00142	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000711	0.00138	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SERPINE1—Behcet's disease	0.00067	0.0013	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—APOA1—Behcet's disease	0.00065	0.00126	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS3—Behcet's disease	0.00064	0.00124	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CAT—Behcet's disease	0.000632	0.00122	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APOB—Behcet's disease	0.000613	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ICAM1—Behcet's disease	0.000601	0.00116	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—APOA1—Behcet's disease	0.000591	0.00114	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000591	0.00114	CbGpPWpGaD
Vemurafenib—RAF1—Disease—APOA1—Behcet's disease	0.000584	0.00113	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—APOA1—Behcet's disease	0.000579	0.00112	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—Behcet's disease	0.000576	0.00111	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000562	0.00109	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CAT—Behcet's disease	0.000556	0.00108	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOB—Behcet's disease	0.000539	0.00104	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000523	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOB—Behcet's disease	0.000517	0.001	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SERPINE1—Behcet's disease	0.000516	0.000998	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS3—Behcet's disease	0.000492	0.000952	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APOA1—Behcet's disease	0.000485	0.000938	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SERPINE1—Behcet's disease	0.000469	0.000908	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—Behcet's disease	0.000466	0.000901	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SERPINE1—Behcet's disease	0.000464	0.000897	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SERPINE1—Behcet's disease	0.00046	0.000889	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOS3—Behcet's disease	0.000448	0.000867	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS3—Behcet's disease	0.000443	0.000857	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS3—Behcet's disease	0.000439	0.000849	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOA1—Behcet's disease	0.000427	0.000826	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000414	0.0008	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOA1—Behcet's disease	0.000409	0.000792	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—Behcet's disease	0.000398	0.000769	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NOS3—Behcet's disease	0.000368	0.000711	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAT—Behcet's disease	0.000343	0.000663	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOB—Behcet's disease	0.000333	0.000644	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SERPINE1—Behcet's disease	0.000325	0.000628	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—Behcet's disease	0.000323	0.000626	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—Behcet's disease	0.00031	0.0006	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAT—Behcet's disease	0.000283	0.000548	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—Behcet's disease	0.000275	0.000532	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOB—Behcet's disease	0.000275	0.000532	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOA1—Behcet's disease	0.000263	0.00051	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAT—Behcet's disease	0.00024	0.000464	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOB—Behcet's disease	0.000233	0.00045	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOA1—Behcet's disease	0.000217	0.000421	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—Behcet's disease	0.0002	0.000386	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAT—Behcet's disease	0.000185	0.000358	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOA1—Behcet's disease	0.000184	0.000356	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOB—Behcet's disease	0.00018	0.000348	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—Behcet's disease	0.000165	0.000319	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA1—Behcet's disease	0.000142	0.000275	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—Behcet's disease	0.00014	0.00027	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—Behcet's disease	0.000108	0.000208	CbGpPWpGaD
